e-learning
resources
Munich 2014
Sunday, 07.09.2014
Monitoring COPD with different biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The association between objective CT measures of bronchiectasis and health-related quality of life in COPD
A. Diaz, J. Ross, G. Washko, R. San Jose Estepar (Boston, United States Of America)
Source:
International Congress 2014 – Monitoring COPD with different biomarkers
Session:
Monitoring COPD with different biomarkers
Session type:
Oral Presentation
Number:
207
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Diaz, J. Ross, G. Washko, R. San Jose Estepar (Boston, United States Of America). The association between objective CT measures of bronchiectasis and health-related quality of life in COPD. Eur Respir J 2014; 44: Suppl. 58, 207
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Assessment of quality of life of bronchiectasis patients associated with asthma and COPD.
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019
The pulmonary artery-aorta ratio, exacerbation rate and quality of life in stable COPD patients
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014
Clinical differences between emphysematous and non-emphysematous COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Predictive role of mMRC scale on quality of life in COPD patients
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013
Quality of life in obstructive lung diseases
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
Health-related quality of life in emphysema due to alpha-1-antitrypsin deficiency
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013
The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Discordant symptom severity in COPD: The PHAROAH study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Assessment of quality of life in patients with bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
COPD assessment test (CAT): Validity and reproducibility in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Physiotherapy assessment and techniques in pulmonary and non-pulmonary conditions
Year: 2015
Bronchial hyperresponsiveness as a predictor of treatment-response in COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Impact of obesity on markers of asthma severity, control, health-related quality of life (HrQOL) and eosinophilia
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Which are the main determinants of quality-of-life in severe asthma?
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Responsiveness of the clinical COPD questionaire to pulmonary rehabilitation
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Concordance between airway inflammation and health status in COPD patients with bacterial colonisation
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Reduction in clinically important deterioration in COPD with aclidinium/formoterol
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Cough is an independent contributor to health-related quality of life impairment in COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT)
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept